In a follow-up letter, Rep. Waxman asks HHS Secretary Thompson for a complete list of marketed prescription drugs that do not have FDA approval as well as those that in the past lacked FDA approval and were subsequently either approved or taken off the market. Rep. Waxman also urges Secretary Thompson to instruct the FDA to require approval of the pancreatic enzyme drugs used by patients with cystic fibrosis.